|[May 08, 2014]
Nordic Nanovector: Notice of Annual General Meeting 2014
OSLO, Norway --(Business Wire)--
The Annual General meeting in Nordic Nanovector AS will be held on
Wednesday May 14, 2014 at 10:00 CET in the Company's offices at
Kjelsåsveien 168 B, 4th floor, Oslo.
Below please find the agenda, attendance form and the Annual report for
About Nordic Nanovector AS
Nordic Nanovector AS is a privately held company established in 2009.
The company is based in Norway and has offices and laboratories in Oslo.
The company is developing novel innovative anticancer
radioimmunotherapeutics to treat Non-Hodgkin Lymphoma (NHL) and other
Betalutin™, is a pharmaceutical product candidate consisting of a
radionuclide conjugated to a tumor seeking carrier/antibody, which can
be used for irradiation of malignant metastasized tumors with minimal
damage to nearby healthy normal tissue. This technology aims to prolong
and improve the quality of life of people who suffer from non-Hodgkin
This information was brought to you by Cision http://news.cision.com
[ Back To TMCnet.com's Homepage ]